AI - Biostache

Recent Articles..

To The Moon: Our Interview With ResearchSat
Recently, I had the chance to sit down and chat with ResearchSat’s founder/CEO RaviTeja Duggineni and their head of investor relations, Rahul Kundnani.
The Might of Mesoblast: How Perseverance Paid Off
Last year, Mesoblast Ltd had their therapeutic RYONCIL approved by the FDA. This article touches on the journey to get to this milestone.
Who needs a heartbeat? BiVACOR The New Artificial Titanium Heart
Heart disease remains one of the leading causes of death globally, BiVACOR may be the solution to this – a total artificial heart that utilises a single motor with MAGLEV technology to pump blood to the lungs and body.
The Micro Apocalypse: Antimicrobial Resistance
Antibiotics are arguably one of the most important biotechnological inventions of the last century. Access to effective antibiotic and antimicrobial drugs has saved countless lives, and allowed for advancements in healthcare, increasing the success of other medical interventions such as surgery and chemotherapy.
Here’s why last week’s stock market crash is a warning sign for Australia’s biotech sector
Investments in biotechnology are most impactful when made by those with deep pockets. The aim of the game is to make a return on investment, …
Read more "Here’s why last week’s stock market crash is a warning sign for Australia’s biotech sector"

AI Driven Biotechnology – A New Era of Digital Redundancy?

by Daniel GiannettiAI, Biotechnology April 24, 2024April 25, 20242 Comments

Linkedin Instagram The Emergence of AI in Biotechnology The integration of Artificial Intelligence (AI) across various industries has been nothing short of revolutionary and has completely transformed many different sectors. AI is helping these industries improve in efficiency, accuracy and scope. Is this the case in the field of Biotechnology? This article explores the ways …